Bessemer Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-88
Closed -$4K 2385
2023
Q2
$4K Buy
88
+83
+1,660% +$3.36K ﹤0.01% 1909
2023
Q1
$0 Buy
+5
New +$181 ﹤0.01% 2111
2022
Q4
Sell
-220
Closed -$8.7K 2201
2022
Q3
$10K Sell
220
-103,767
-100% -$6.7M ﹤0.01% 1562
2022
Q2
$7.45M Buy
103,987
+103,691
+35,031% +$7.58M 0.02% 249
2022
Q1
$24K Buy
296
+156
+111% +$13.2K ﹤0.01% 1218
2021
Q4
$15K Hold
140
﹤0.01% 1339
2021
Q3
$12K Buy
140
+94
+204% +$8.51K ﹤0.01% 1342
2021
Q2
$4K Hold
46
﹤0.01% 1460
2021
Q1
$3K Sell
46
-213
-82% -$16.1K ﹤0.01% 1450
2020
Q4
$18K Buy
259
+213
+463% +$13.3K ﹤0.01% 1194
2020
Q3
$2K Hold
46
﹤0.01% 1293
2020
Q2
$3K Sell
46
-46
-50% -$2.47K ﹤0.01% 1636
2020
Q1
$4K Hold
92
﹤0.01% 1516
2019
Q4
$5K Hold
92
﹤0.01% 1496
2019
Q3
$5K Hold
92
﹤0.01% 1546
2019
Q2
$5K Buy
+92
New +$4.28K ﹤0.01% 1541
2019
Q1
Sell
-1,500
Closed -$59K 2025
2018
Q4
$59K Buy
+1,500
New +$69.7K ﹤0.01% 1284
2016
Q4
Sell
-681
Closed -$30K 2089
2016
Q3
$30K Buy
+681
New +$29.5K ﹤0.01% 1295

Other funds holding SYNH

Bessemer Group's SYNH Position: Q3 2023 in Review

Bessemer Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 88 shares — an estimated $4K sold.

Bessemer Group first reported a position in SYNH in Q3 2016 and held it in 18 quarters. The position peaked at $7.45M in Q2 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Bessemer Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bessemer Group sold 88 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4K.
  • Bessemer Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 18 quarters.
  • Bessemer Group's Syneos Health, Inc. Class A Common Stock position peaked at $7.45M in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bessemer Group's 13F filing for Q3 2023, filed 13 Nov 2023.